Evidence map›Paper›PMID 24058462›Full record

ArticlePloS one2013

Pseudomonas aeruginosa utilizes the type III secreted toxin ExoS to avoid acidified compartments within epithelial cells.

Susan R Heimer, David J Evans, Michael E Stern, Joseph T Barbieri, Timothy Yahr, Suzanne M J Fleiszig

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. ThemBio · 2025
    Article
  6. Article
  7. Article
  8. The Role ofPharmaceutics · 2024
    Review
  9. Article
  10. Evidence for intracellularJournal of bacteriology · 2024
    Review
  11. The L-lactate dehydrogenases ofbioRxiv : the preprint server for biology · 2024
    Article
  12. Article
  13. Outsmarting Pathogens with Antibody Engineering.Annual review of chemical and biomolecular engineering · 2023
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Modulation of the immune response by theFrontiers in cellular and infection microbiology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Susan R HeimerSchool of Optometry, University of California, Berkeley, California, United States of America ; College of Pharmacy, Touro University California, Vallejo, California, United States of America.
David J Evans
Michael E Stern
Joseph T Barbieri
Timothy Yahr
Suzanne M J Fleiszig
Touro University California · USAllergan (United States) · USMedical College of Wisconsin · USUniversity of California, Berkeley · USUniversity of Iowa · US

Funding

Mechanisms of Bacterial Toxin ActionR01AI030162 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI BARBIERI, JOSEPH T · 1990 to 2019
$6.7M
Regulation of Pseudomonas aeruginosa type III secretionR01AI055042 · NIAID · UNIVERSITY OF IOWA · PI YAHR, TIMOTHY L · 2003 to 2021
$4.4M
INTRACELLULAR LIFESTYLE OF PSEUDOMONAS AERUGINOSAR01AI079192 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI FLEISZIG, SUZANNE MJ · 2009 to 2013
$2.0M
Regulation of Pseudomonas aeruginosa type III secretionR56AI055042 · NIAID · UNIVERSITY OF IOWA · PI YAHR, TIMOTHY L · 2016 to 2016
$339k
NIAID NIH HHS AI030162NIAID NIH HHS AI055042NIAID NIH HHS AI079192NIAID NIH HHS R01 AI030162NIAID NIH HHS R01 AI055042NIAID NIH HHS R01 AI079192NIAID NIH HHS R56 AI055042
6 · The paper itself

Abstract

Invasive Pseudomonas aeruginosa (PA) can enter epithelial cells wherein they mediate formation of plasma membrane bleb-niches for intracellular compartmentalization. This phenotype, and capacity for intracellular replication, requires the ADP-ribosyltransferase (ADPr) activity of ExoS, a PA type III secretion system (T3SS) effector protein. Thus, PA T3SS mutants lack these capacities and instead traffic to perinuclear vacuoles. Here, we tested the hypothesis that the T3SS, via the ADPr activity of ExoS, allows PA to evade acidic vacuoles that otherwise suppress its intracellular viability. The acidification state of bacteria-occupied vacuoles within infected corneal epithelial cells was studied using LysoTracker to visualize acidic, lysosomal vacuoles. Steady state analysis showed that within cells wild-type PAO1 localized to both membrane bleb-niches and vacuoles, while both exsA (transcriptional activator) and popB (effector translocation) T3SS mutants were only found in vacuoles. The acidification state of occupied vacuoles suggested a relationship with ExoS expression, i.e. vacuoles occupied by the exsA mutant (unable to express ExoS) were more often acidified than either popB mutant or wild-type PAO1 occupied vacuoles (p < 0.001). An exoS-gfp reporter construct pJNE05 confirmed that high exoS transcriptional output coincided with low occupation of acidified vacuoles, and vice versa, for both popB mutants and wild-type bacteria. Complementation of a triple effector null mutant of PAO1 with exoS (pUCPexoS) reduced the number of acidified bacteria-occupied vacuoles per cell; pUCPexoSE381D which lacks ADPr activity did not. The H(+)-ATPase inhibitor bafilomycin rescued intracellular replication to wild-type levels for exsA mutants, showing its viability is suppressed by vacuolar acidification. Taken together, the data show that the mechanism by which ExoS ADPr activity allows intracellular replication by PA involves suppression of vacuolar acidification. They also show that variability in ExoS expression by wild-type PA inside cells can differentially influence the fate of individual intracellular bacteria, even within the same cell.

Indexed as

Gene Expression Regulation, BacterialADP Ribose TransferasesAminesAntigens, BacterialBacterial ProteinsBacterial ToxinsBiological TransportCell LineCell MembraneCytoplasmEpithelial CellsEpithelium, CornealGenes, ReporterGenetic Complementation TestGreen Fluorescent ProteinsHost-Pathogen InteractionsADP Ribose TransferasesAminesAntigens, BacterialBacterial ProteinsBacterial Toxinsexoenzyme SExsA protein, Pseudomonas aeruginosaGreen Fluorescent ProteinsPopB protein, Pseudomonas aeruginosaRecombinant Fusion ProteinsRed DND-99Trans-Activators

Identifiers

PMID24058462
PMCPMC3776860
OpenAlexW2081234424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.